SCHEMBL4601926

SCHEMBL4601926

CCCOc1ccc(-c2cccc(OC)c2F)cc1C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 5/20 0.58
DHODH Q02127 2/20 0.51
PTPN1 P18031 1/20 0.46
PTPN6 P29350 1/20 0.46
CTSA P10619 2/20 0.45
PDE4D Q08499 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44
NPC1 O15118 1/20 0.43
CYP2C9 P11712 1/20 0.43
RAB9A P51151 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CD274 Q9NZQ7 1/20 0.43
ERN1 O75460 1/20 0.43
MRGPRX4 Q96LA9 1/20 0.43
METAP2 P50579 1/20 0.42
MCL1 Q07820 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4602608 0.91 DHODH (0.53) PTPN11DHODHCTSACD274ERN1
SCHEMBL4602008 0.88 PTPN11 (0.60) PTPN11DHODHPTPN1PTPN6CTSA
SCHEMBL4601679 0.80 PTPN11 (0.64) PTPN11PTPN1PTPN6
SCHEMBL5154648 0.80 PTPN11 (0.60) PTPN11PTPN1PTPN6PDE4DNPC1
SCHEMBL4601795 0.80 MCL1 (0.56) PTPN11PTPN1PTPN6CTSAFFAR4
SCHEMBL4602266 0.79 PTPN11 (0.64) PTPN11PTPN1PTPN6MCL1
SCHEMBL4602341 0.79 MCL1 (0.61) PTPN11DHODHPTPN1PTPN6FFAR4
SCHEMBL4603210 0.78 PTPN11 (0.62) PTPN11DHODHPTPN1PTPN6FFAR4
SCHEMBL4602854 0.78 PTPN11 (0.57) PTPN11PTPN1PTPN6FFAR4MCL1
SCHEMBL14610430 0.78 PTPN11 (0.47) PTPN11CTSAPDE4DFFAR4MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO claimed
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R PTPN11 3529/4885DHODH 3439/4885PTPN1 3489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.